2021 | 2022 | 2023 | |
---|---|---|---|
Revenue | $0 | $0 | $5K |
Cost of Revenue | $0 | $3.4K | $0 |
Gross Profit | $0 | -$3.4K | $5K |
Gross Profit % | 0% | 0% | 100% |
R&D Expenses | $186K | $0 | $0 |
2021 | 2022 | 2023 | |
---|---|---|---|
Net Income | -$262K | -$1.3M | -$6.8M |
Dep. & Amort. | $0 | $3.4K | $52K |
Def. Tax | $0 | $0 | $0 |
Stock Comp. | $0 | $0 | $0 |
Chg. in WC | $32K | -$346K | $627K |
2021 | 2022 | 2023 | |
---|---|---|---|
Cash | $238K | $7.5M | $3.2M |
ST Investments | $0 | $0 | $0 |
Cash & ST Inv. | $238K | $7.5M | $3.2M |
Receivables | $0 | $0 | $0 |
Inventory | $0 | $0 | $0 |
MGAM reported a 3.7% organic revenue growth in 2024, with faster-growing markets like healthcare, clean energy, and clean transportation achieving 7.6% growth.
Group adjusted operating profit was £128.4 million, with an operating margin of 11.7%, up 90 basis points. Restructuring efforts are expected to deliver £27 million in annual savings by 2026 at a one-off cost of £45 million.
Semiconductor revenues were flat for the year, with a decline in the second half due to slower-than-expected electric vehicle growth. Growth is expected to return in 2026 as inventory levels normalize.
Capital expenditure guidance includes £90 million for 2025, £65 million for 2026, and £60 million for 2027, with reduced semiconductor investments due to market conditions. Net debt to EBITDA is expected to remain within the range of 1.4x to 1.5x.
For 2025, MGAM anticipates mid-single-digit revenue declines due to headwinds in industrial and semiconductor markets, partially offset by growth in clean energy, transportation, aerospace, and defense. Margins are expected to return to the target range of 12.5%-15%.